RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Hepion Pharmaceuticals Market capitalization 2024

Hepion Pharmaceuticals Market capitalization

4.53 M USD

Hepion Pharmaceuticals Dividend yield

Ticker

HEPA

ISIN

US4268971045

WKN

A2PN6W

In 2024, Hepion Pharmaceuticals's market cap stood at 4.53 M USD, a -90.16% increase from the 45.98 M USD market cap in the previous year.

The Hepion Pharmaceuticals Market capitalization history

YEARREVENUE (undefined USD)GROSS MARGIN (%)NET INCOME (undefined USD)
2030e123.01-111.59
2029e460.02--1,115.88
2028e225.42--26,223.18
2027e---35,373.39
2026e---35,987.13
2025e---29,012.88
2024e---63,772.54
2023---48,926.04
2022---45,340
2021---32,720
2020---20,360
2019---12,480
2018---17,900
2017---14,890
2016---17,000
2015---22,190
2014---5,280
2013---5,280
2012---140

Hepion Pharmaceuticals Aktienanalyse

What does Hepion Pharmaceuticals do?

Hepion Pharmaceuticals Inc. is a biopharmaceutical company focused on researching and developing therapeutics for the treatment of liver diseases. The company was founded in 2013 and is headquartered in Edison, New Jersey. The history of Hepion Pharmaceuticals Inc. began with the discovery of a new approach to treating liver diseases. Researchers found that small molecules targeting specific cells in the liver could have a positive effect on liver function. Hepion used this discovery as a starting point for developing new drugs to treat liver diseases. Hepion Pharmaceuticals Inc.'s business model is based on the development and marketing of innovative therapeutics for a variety of liver diseases, including fatty liver disease, alcoholic liver disease, non-alcoholic steatohepatitis (NASH), liver fibrosis, liver cirrhosis, and liver cancer. Hepion Pharmaceuticals has several divisions, all focused on the development of therapeutics for liver diseases. The primary division is research and development, which focuses on identifying and developing new drugs for the liver. Another important division is clinical development, where the drugs are tested and validated in clinical trials. The third division is marketing, where the therapeutics are marketed and sold. Hepion Pharmaceuticals Inc. currently offers two products. The first product is CRV431, a top-notch inhibitor of cytokine-mediated signaling. It is an orally administered drug specifically developed for the treatment of liver fibrosis. CRV431 aims to inhibit cytokine-mediated signaling responsible for fibrosis formation. The second product is an idiosyncratic database marketed under the name AI-Enabler. It is touted by the company as a groundbreaking tool for more precise medicine and research in support of drug development work. Overall, Hepion Pharmaceuticals Inc. is a promising biopharma company with a clear focus on developing new drugs for the treatment of liver diseases. With its innovative products and expertise in research and development, the company collaborates closely with partners from the scientific, industrial, and governmental sectors. It is hoped that this company will make further pioneering discoveries in the future and contribute to the benefit of human health. Hepion Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Hepion Pharmaceuticals's Market Capitalization

Hepion Pharmaceuticals's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Hepion Pharmaceuticals's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Hepion Pharmaceuticals's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Hepion Pharmaceuticals’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Hepion Pharmaceuticals Stock

What is the current Hepion Pharmaceuticals market capitalization?

The current market capitalization of Hepion Pharmaceuticals is 4.53 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Hepion Pharmaceuticals.

How has the market capitalization of Hepion Pharmaceuticals developed in recent years?

The market capitalization of Hepion Pharmaceuticals has increased/decreased by -90.16% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Hepion Pharmaceuticals?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Hepion Pharmaceuticals?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Hepion Pharmaceuticals have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Hepion Pharmaceuticals pay?

Over the past 12 months, Hepion Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hepion Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Hepion Pharmaceuticals?

The current dividend yield of Hepion Pharmaceuticals is .

When does Hepion Pharmaceuticals pay dividends?

Hepion Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hepion Pharmaceuticals?

Hepion Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Hepion Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hepion Pharmaceuticals located?

Hepion Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hepion Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hepion Pharmaceuticals from 5/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/24/2024.

When did Hepion Pharmaceuticals pay the last dividend?

The last dividend was paid out on 5/24/2024.

What was the dividend of Hepion Pharmaceuticals in the year 2023?

In the year 2023, Hepion Pharmaceuticals distributed 0 USD as dividends.

In which currency does Hepion Pharmaceuticals pay out the dividend?

The dividends of Hepion Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Hepion Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Hepion Pharmaceuticals

Our stock analysis for Hepion Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hepion Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.